Blackstone has raised $4.2 billion toward a roughly $4.6 billion target for the firm’s fifth life sciences fund, according to an SEC filing. The firm originally launched its life sciences division in 2018 when it acquired Clarus, pledging to invest in late-stage life sciences companies looking to bring their drugs to market.
Read the full article: Blackstone Brings in $4.2B for Life Sciences Vehicle //
Source: https://pitchbook.com/newsletter/blackstone-brings-in-42b-for-life-sciences-vehicle